FIELD: medicine.
SUBSTANCE: gene of human vascular endothelial growth factor (VEGF) optimised for expression in mammal cells is presented.
EFFECT: due to introduction of VEGFopt gene into pC4W-VEGFopt plasmid, the invention allows improving the yield of an end product in 1,5 times in comparison with the technology of pC4W-hVEGF165 plasmid containing a natural gene.
3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGPopt GENE OF ANGIOPOIETIN-1 | 2008 |
|
RU2385938C1 |
HGFopt GENE OF HEPATOCYTE GROWTH FACTOR | 2008 |
|
RU2385936C1 |
METALLOPROTEINASE-1 MMP1opt GENE | 2008 |
|
RU2378377C1 |
METALLOPROTEINASE-8 MMP8opt GENE | 2008 |
|
RU2378376C1 |
METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
GENETIC ENGINEERING STRUCTURE FOR ANGIOGENESIS STIMULATION | 2019 |
|
RU2737487C1 |
METHOD FOR LOCALLY SUPPRESSING ANGIOGENESIS IN TARGET TISSUE | 2005 |
|
RU2292395C1 |
AGENT PROMOTING THERAPEUTIC ANGIOGENESIS AND METHOD FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2449799C2 |
AGENT FOR TREATMENT OF ISCHEMIC LESIONS OF TISSUES AND METHOD OF ITS USE | 2012 |
|
RU2522778C2 |
EXPRESSION VECTOR FOR PROTEIN SYNTHESIS IN MAMMALIAN CELLS | 2007 |
|
RU2364627C2 |
Authors
Dates
2010-04-10—Published
2008-06-25—Filed